169 related articles for article (PubMed ID: 8950339)
1. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
Ashraf MS; Skinner R; English MW; Craft AW; Pearson AD
Med Pediatr Oncol; 1997 Jan; 28(1):62-4. PubMed ID: 8950339
[TBL] [Abstract][Full Text] [Related]
2. Chronic ifosfamide nephrotoxicity in children.
Skinner R
Med Pediatr Oncol; 2003 Sep; 41(3):190-7. PubMed ID: 12868118
[TBL] [Abstract][Full Text] [Related]
3. Reversible hypophosphatemic rickets following ifosfamide treatment.
Van Gool S; Brock P; Wijndaele G; Van de Casseye W; Kruger M; Proesmans W; Casteels-Van Daele M
Med Pediatr Oncol; 1992; 20(3):254-7. PubMed ID: 1574040
[TBL] [Abstract][Full Text] [Related]
4. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients.
Rossi R; Pleyer J; Schäfers P; Kuhn N; Kleta R; Deufel T; Jürgens H
Med Pediatr Oncol; 1999 Mar; 32(3):177-82. PubMed ID: 10064184
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.
Skinner R; Cotterill SJ; Stevens MC
Br J Cancer; 2000 May; 82(10):1636-45. PubMed ID: 10817497
[TBL] [Abstract][Full Text] [Related]
6. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
Burk CD; Restaino I; Kaplan BS; Meadows AT
J Pediatr; 1990 Aug; 117(2 Pt 1):331-5. PubMed ID: 2166154
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
Oberlin O; Fawaz O; Rey A; Niaudet P; Ridola V; Orbach D; Bergeron C; Defachelles AS; Gentet JC; Schmitt C; Rubie H; Munzer M; Plantaz D; Deville A; Minard V; Corradini N; Leverger G; de Vathaire F
J Clin Oncol; 2009 Nov; 27(32):5350-5. PubMed ID: 19826134
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the accuracy and utility of early markers of Ifosfamide-induced proximal tubulopathy in survivors of childhood cancers.
Phillips RS; Tyerman K; Al-Kassim MI; Picton S
Pediatr Hematol Oncol; 2008 Mar; 25(2):107-13. PubMed ID: 18363176
[TBL] [Abstract][Full Text] [Related]
11. End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
Friedlaender MM; Haviv YS; Rosenmann E; Peylan-Ramu N
Am J Nephrol; 1998; 18(2):131-3. PubMed ID: 9569955
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide induced renal rickets.
Lionel AP; Chinnaswamy G; John RR; Mathai S
Indian J Pediatr; 2014 Sep; 81(9):943-5. PubMed ID: 23912821
[TBL] [Abstract][Full Text] [Related]
13. Renal dysfunctions secondary to ifosfamide treatment in children.
Tokuc G; Yalçiner A; Kebudi R; Dogan S; Görgün O; Ayan I
J Exp Clin Cancer Res; 1997 Jun; 16(2):227-30. PubMed ID: 9261752
[TBL] [Abstract][Full Text] [Related]
14. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
Rossi RM; Kist C; Wurster U; Külpmann WR; Ehrich JH
Pediatr Nephrol; 1994 Apr; 8(2):151-6. PubMed ID: 8018491
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide and paediatrics: should this marriage be saved?
Womer RB
Eur J Cancer; 1996 Jun; 32A(7):1100-1. PubMed ID: 8758237
[No Abstract] [Full Text] [Related]
16. Ifosfamide nephrotoxicity in paediatric cancer patients.
Ashraf MS; Brady J; Breatnach F; Deasy PF; O'Meara A
Eur J Pediatr; 1994 Feb; 153(2):90-4. PubMed ID: 8157032
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children.
Loebstein R; Atanackovic G; Bishai R; Wolpin J; Khattak S; Hashemi G; Gobrial M; Baruchel S; Ito S; Koren G
J Clin Pharmacol; 1999 May; 39(5):454-61. PubMed ID: 10234592
[TBL] [Abstract][Full Text] [Related]
18. [Ifosfamide-induced nephrotoxicity].
Rossi R; Rath B; Ullrich K; Ehrich JH
Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide nephrotoxicity in children: histopathological features in two cases.
Morland BJ; Mann JR; Milford DV; Raafat F; Stevens MC
Med Pediatr Oncol; 1996 Jul; 27(1):57-61. PubMed ID: 8614393
[TBL] [Abstract][Full Text] [Related]
20. [Ifosphamide nephrotoxicity].
Ensergueix G; Karras A
Nephrol Ther; 2018 Apr; 14 Suppl 1():S125-S131. PubMed ID: 29606257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
